Novo Nordisk Inc. et al v. Sun Pharmaceutical Industries, Inc., et al
| Novo Nordisk Inc. and Novo Nordisk A/S |
| Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc. |
| 1:2022cv00897 |
| July 1, 2022 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 22, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 9 MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter and Olivia L. Wheeling - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) |
SO ORDERED, re (11 in 1:22-cv-00936-CFC, 8 in 1:22-cv-00856-CFC, 11 in 1:22-cv-00937-CFC, 9 in 1:22-cv-00896-CFC, 9 in 1:22-cv-00897-CFC) MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter and Olivia L. Wheeling, filed by Novo Nordisk A/S, Novo Nordisk Inc. Ordered by Judge Colm F. Connolly on 8/22/2022. Associated Cases: 1:22-cv-00856-CFC, 1:22-cv-00896-CFC, 1:22-cv-00897-CFC, 1:22-cv-00936-CFC, 1:22-cv-00937-CFC(kmd)
|
| Filing 8 WAIVER OF SERVICE returned executed by Novo Nordisk Inc., Novo Nordisk A/S: For Sun Pharmaceutical Industries, Inc. waiver sent on 7/6/2022, answer due 9/6/2022. (Egan, Brian) |
| Filing 7 WAIVER OF SERVICE returned executed by Novo Nordisk Inc., Novo Nordisk A/S: For Sun Pharmaceutical Industries Ltd. waiver sent on 7/6/2022, answer due 9/6/2022. (Egan, Brian) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Filing 6 Summons Issued as to Sun Pharmaceutical Industries Ltd. on 7/1/2022; Sun Pharmaceutical Industries, Inc. on 7/1/2022. (Attachments: #1 Summons Issued)(srs) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo Nordisk A/S and Corporate Parent Novo Nordisk US Holdings, Inc. for Novo Nordisk Inc. filed by Novo Nordisk A/S and Novo Nordisk Inc. (srs) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,579,869 B2 ;7,762,994 B2 ;8,114,833 B2 ;9,265,893 B2. (srs) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/19/2022. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 11/19/2024. (srs) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs) |
| Filing 1 COMPLAINT filed against Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc. ( Filing fee $ 402, receipt number ADEDC-3908452.) - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: #1 Exhibit A-D, #2 Civil Cover Sheet)(srs) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
